Biobank
/
Eastern Norway

Life Technologies AS
Biotechnology, diagnostics & therapy tools

Africa
Asia
Denmark
Europe
North America
Oceania
South America
South Asia
Sweden
West Asia
  • Finance
    Total revenues: 1.097.920
    Operating profit : 673.034
    Operating profit before tax: 666.785
    Total assets: 3.293.416
    Total equity: 267.724
    Currency: NOK (all numbers in thousands)
  • Management
    Board Chairman:
    Der Zande Petrus Tho Van

    Board Members:
    Anette Kullmann
    Geir Hetland
    Hanne-Sofie Pedersen
    Jack Andreassen

    General Manager:
    Hanne-Sofie Pedersen

    Subsidiary companies:
    Largest shareholders:
    N/A
  • Trademarks
    Dynabeads,
Dynabeads,
    Biobank, Biomagnetic separation systems, Bioseparation Products, Biotechnology, blood-forming organs and the cardiovascular system, chemical products and man-made fibres, Chemical reagents, Chemicals, Diagnostic agents, Diagnostic products, Diagnostic supplies, Injectable solutions, Insulin, Management holdings services, Medical and laboratory devices, Medical solutions, Medicinal products, Medicinal products for the alimentary tract and metabolism, Medicinal products for the blood, Medicinal products for the blood and blood-forming organs, Medicinal products for the cardiovascular system, optical and precision devices, pharmaceuticals and related medical consumables, Plastic products, Reagents and contrast media, Research and experimental development services, Specialised chemical products, Vitamins, watches and clocks, X-ray contrast media,